The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
This study has been terminated.
Study NCT00002420
Information provided by Bristol-Myers Squibb
First Received: November 2, 1999
Last Updated: August 13, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
